Web Site With Free Pathways for the Biology and Chemistry Community

GeneGo Launches New Web Site With Free Pathways for the Biology and Chemistry
Community



ST. JOSEPH, Mich., Oct. 29 /PRNewswire/ -- GeneGo, Inc., the leading systems
biology tools company, announced today that they will be launching a new web
site with FREE high quality pathway content.  On www.genego.com, anyone can
now search for genes, proteins, compounds, processes and diseases and access
high quality manually curated pathway maps for human, mouse and rat signaling
and metabolism. Every step on the pathways is supported by high quality "small
experiment" evidence.  The web site includes 37 Cystic Fibrosis specific
disease maps, the result of a collaborative development project with Cystic
Fibrosis Foundation (CFF).

GeneGo's new web site also features a new community career section
http://www.genego.com/careers.php that anyone can advertise open positions at
their companies or institutions. Furthermore, the web site also includes
sections with the latest publications using GeneGo technology; it can be
searched and there is also product information, events and training sessions
on line and at many locations throughout the world.

"With the number of our academic users growing rapidly and GeneGo working with
companies to set industry standards, we wanted to 'give back' to the life
science community that has been loyal to GeneGo for years," said Julie Bryant,
GeneGo's VP of Business development. "For the first time, we are now providing
free pathway maps that have been expensive to build and a section to help
people find jobs in these tough times.  We plan to add more 'community
services' in the next 12 months."

About GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based
pathway analysis, cheminformatics & bioinformatics software for life science
research. The original computational MetaDiscovery(TM) platform allows an
integration and expert analysis of different kinds of experimental data (mRNA
expression, proteomics, metabolomics, microRNA assays and other phenotypic
data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics)
within the framework of curated biological pathways and networks. GeneGo's
flagship product, MetaCore 6.0(TM), assists pharmaceutical scientists in the
areas of target selection and validation, data mining in biology,
identification of biomarkers for disease states and toxicology. The second
product, MetaDrug 6.0(TM) is designed for prediction of human metabolism,
toxicity and biological effects for novel small molecules compounds.
MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.